Labshake search
Citations for R&D Systems :
51 - 100 of 2559 citations for Recombinant Human Serpin Peptidase Inhibitor Clade B ovalbumin Member 9 His tagged since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2022Quote: ... Recombinant human MBL (R&D systems) was reconstituted in PBS and serially diluted from 10μg/ml by two-fold dilution ...
-
bioRxiv - Physiology 2022Quote: ... Recombinant human WNT3A (R&D Systems) and recombinant human Norrin (R&D Systems ...
-
bioRxiv - Neuroscience 2023Quote: ... recombinant human BMP4 (R&D Systems) was added at 1.5 nM (55 ng/ml)7 ...
-
bioRxiv - Bioengineering 2024Quote: ... Recombinant human VEGF (R&D Systems) was added to the basal media at 20 ng/mL immediately prior to cell treatment ...
-
bioRxiv - Immunology 2022Quote: ... at 37°C in RPMI medium supplemented with 8% human serum and cultured for 7-9 days in the presence of 50 UI/ml of recombinant IL-2 (R&D System).
-
bioRxiv - Pathology 2021Quote: ... mouse anti-TGF-β and goat anti-Serpin F1/PEDF (R&D Systems), rabbit anti-Uteroglobin ...
-
bioRxiv - Neuroscience 2020Quote: ... the antibody was pretreated with or without 5x recombinant human plexin-B3 (His45-Gln1255 (Gln1156Asp) with a C-terminal 6-His tag) (R&D systems) overnight.
-
bioRxiv - Biochemistry 2021Quote: Human anti-SP IgG or ACE-2 Fc was mixed with recombinant SARS-CoV-2 spike RBD His tag (R&D Systems) or recombinant SARS-CoV-2 spike RBD (N501Y)-His tag (Sino Biological ...
-
bioRxiv - Neuroscience 2023Quote: ... member 3A (Wnt3A) (10 ng/mL, R&D Systems) and cyclopamine (1 μM ...
-
bioRxiv - Immunology 2023Quote: ... moDCs were treated with recombinant galectin-9 protein (AF2045, R&D systems) at a final concentration of 1 µg/ml.
-
bioRxiv - Cell Biology 2020Quote: 0.3M of purified proteins (recombinant human E-cadherin 8505 and recombinant human EGFR 344-ER R&D system) were mixed and incubated in 100μl of lysis buffer (25 mM TrisHCl pH 7.5 ...
-
bioRxiv - Neuroscience 2021Quote: ... recombinant human M-CSF (R&D Systems), 100 μg/mL streptomycin ...
-
bioRxiv - Immunology 2019Quote: ... Recombinant human TGF-β1 (R&D Systems) was used as positive control ...
-
bioRxiv - Biophysics 2021Quote: ... Recombinant Human EGF Protein (R&D Systems). Erlotinib hydrochloride (500nM ...
-
bioRxiv - Physiology 2022Quote: ... and recombinant human Norrin (R&D Systems) were used as response comparators ...
-
bioRxiv - Biochemistry 2019Quote: ... Human recombinant EGF protein (R&D Systems) was diluted to 10x in serum free medium ...
-
bioRxiv - Cancer Biology 2020Quote: ... Human Recombinant TGF-β1 (R&D Systems) was reconstituted in 4mM HCl ...
-
bioRxiv - Immunology 2022Quote: ... recombinant human MMP-8 (R&D Systems) was subjected to the same conditions ...
-
bioRxiv - Immunology 2022Quote: Recombinant human Eotaxin-1 (R&D systems) and recombinant IL-5 (R&D systems ...
-
bioRxiv - Biophysics 2022Quote: ... recombinant human TGF-β1 (R&D systems) was used to induce EMT at a concentration of 2 ng/mL for 24 h ...
-
bioRxiv - Cell Biology 2022Quote: ... Recombinant human Interferon Gamma (R&D Systems), OADC supplement (R&D Systems) ...
-
PVT1, a YAP1 dependent stress responsive lncRNA drives ovarian cancer metastasis and chemoresistancebioRxiv - Cancer Biology 2022Quote: ... epithelial to mesenchymal transition (EMT) was induced with 200 pM of Human recombinant TGF-beta 1 (R&D Systems, 240-B); verteporfin (Sigma Aldrich ...
-
bioRxiv - Bioengineering 2023Quote: ... Fibroblasts were treated with or without recombinant human transforming growth factor beta 1 (TGF-β1) protein (240-B, R&D Systems) at 1.25 ng/mL ...
-
bioRxiv - Microbiology 2020Quote: Secretory leukocyte peptidase inhibitor (SLPI) and Boc-Gln-Ala-Arg-7-Amino-4-methylcoumarin (BOC-QAR-AMC) were obtained from R&D systems. Camostat mesylate was obtained from Sigma Aldrich ...
-
bioRxiv - Microbiology 2019Quote: ... BSA (24 - 48 h at 4°C in rotation) for HIS-tagged rPtxS1 and rGαi proteins with mouse monoclonal anti-HIS (1:1000) (R&D Systems, MAB050), for Gαi with mouse monoclonal anti-Gαi (1:500 ...
-
bioRxiv - Cancer Biology 2023Quote: ... Human recombinant EGF (20 ng/mL) and human recombinant FGF (10 ng/mL) (R&D Systems, Minneapolis, MN, USA) were added twice per week.
-
bioRxiv - Immunology 2023Quote: ... recombinant human PD-L1 human IgG1 Fc chimera protein (R&D Systems), or mouse IgG1 isotype antibodies (R&D Systems ...
-
bioRxiv - Bioengineering 2023Quote: ... human fibronectin and human recombinant BMP-2 (R&D systems, Biotechne, UK); recombinant human BMP-2 (Infuse/InductOS® Bone graft kit ...
-
bioRxiv - Molecular Biology 2023Quote: The recombinant human transforming growth factor beta (TGFβ) protein and recombinant human TSP2 protein were obtained from R&D Systems. The SMAD3 Inhibitor SIS3 was procured from Cayman Chemical Company ...
-
bioRxiv - Developmental Biology 2022Quote: Recombinant human BMP4 (R&D systems, 312-BP) was delivered using Affigel Blue beads (BIO-RAD 1537302) ...
-
bioRxiv - Bioengineering 2022Quote: ... and 0.25µM recombinant human CD229 (R&D Systems) in kinetics buffer ...
-
bioRxiv - Molecular Biology 2022Quote: ... Human recombinant TGF-β1 from R&D Systems Inc ...
-
bioRxiv - Developmental Biology 2022Quote: ... recombinant human TGFβ1 (7754-BH, R&D Systems) was used at 5 ng/ml for the TGFβ1 treatment group for 24 hours ...
-
bioRxiv - Developmental Biology 2021Quote: ... human recombinant FGF4 (R&D Systems, Minneapolis, Minnesota) and heparin (Merck ...
-
bioRxiv - Cell Biology 2021Quote: ... recombinant human CXCL1 (275-GR, R&D Systems) was used at 2500 pg/mL concentration in starvation media ...
-
bioRxiv - Cell Biology 2022Quote: ... and human recombinant TNFα from R&D systems. Small interfering RNAs (siRNAs ...
-
bioRxiv - Neuroscience 2022Quote: Recombinant human leptin (R&D Systems #398-LP) was reconstituted at 1 mg/mL in sterile 20 mM Tris-HCl (Fisher Scientific #MT46031CM ...
-
bioRxiv - Cell Biology 2022Quote: ... and/or recombinant human TNFα (R&D Systems).
-
bioRxiv - Molecular Biology 2023Quote: ... and recombinant human TGFβ-1 (R&D Systems) were performed.
-
bioRxiv - Bioengineering 2023Quote: ... recombinant human fibronectin (R&D systems, Biotechne, UK); Laponite (BYK) ...
-
bioRxiv - Bioengineering 2023Quote: ... human recombinant active TGF-β3 (R&D Systems) was supplemented in culture media at specified concentrations for the initial 14 days of culture.
-
bioRxiv - Neuroscience 2024Quote: Recombinant human IgLON5-Fc chimera (R&D Systems) was bound to a 1 ml HiTrap® NHS- activated HP column (GE Healthcare ...
-
bioRxiv - Bioengineering 2024Quote: ... recombinant human GFRA1 (R&D Systems, AF714-SP) along with 50 ng/ml recombinant human GDNF (R&D Systems ...
-
bioRxiv - Neuroscience 2020Quote: ... recombinant mouse interferon-γ and recombinant human interkeukin-8 (R&D Systems, Minneapolis, MN) was prepared in PBS containing 0.1% BSA ...
-
bioRxiv - Cancer Biology 2023Quote: ... and for granzyme B using human Granzyme B DuoSet ELISA (R&D Systems). All ELISAs were performed as per manufacturer’s instructions ...
-
bioRxiv - Immunology 2023Quote: Recombinant Human IL-2 and human TGF-β were from R&D systems. Anti-mouse CD3 and biotin-anti-CD3 (145-2C11 ...
-
bioRxiv - Immunology 2022Quote: ... supplemented with recombinant human IL-4 (50 ng/mL) and recombinant human GM-CSF (100 ng/mL) (R&D Systems, Minneapolis, MN) with one additional supplement of fresh media and cytokines at day 3 of culture as previously described 12 ...
-
bioRxiv - Microbiology 2021Quote: ... Recombinant cathepsin B and cathepsin L were purchased from R&D Systems.
-
bioRxiv - Cell Biology 2020Quote: ... 500ng/ml Recombinant Human Noggin Protein (R&D Systems) and 10μM SB431542 (Tocris ...
-
bioRxiv - Cell Biology 2020Quote: ... recombinant human NOGGIN (100 ng/ml, R&D Systems), recombinant human EGF (50 ng/ml ...